SODIUM CHLORIDE, ADALIMUMAB, LAD191, LAD191 placebo
M-27134-10
Phase 2 small_molecule active
Quick answer
SODIUM CHLORIDE, ADALIMUMAB, LAD191, LAD191 placebo for Moderate-to-severe hidradenitis suppurativa is a Phase 2 program (small_molecule) at Almirall with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Almirall
- Indication
- Moderate-to-severe hidradenitis suppurativa
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active